Surgical bladder-preserving techniques in the management of muscle-invasive bladder cancer (Q38685443)

5 September 2017

title

Surgical bladder-preserving techniques in the management of muscle-invasive bladder cancer (English)

1 reference

5 September 2017

Matthew D Lyons

1

1 reference

5 September 2017

Angela B Smith

series ordinal

2

1 reference

5 September 2017

publication date

24 December 2015

1 reference

5 September 2017

1 reference

5 September 2017

volume

34

1 reference

5 September 2017

issue

6

1 reference

5 September 2017

page(s)

262-270

1 reference

Comparison of transurethral resection to radical therapies for stage B bladder tumors

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Feasibility of transurethral resection for muscle-infiltrating carcinoma of the bladder: prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Feasibility of transurethral resection for muscle infiltrating carcinoma of the bladder: long-term followup of a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Feasibility of radical transurethral resection as monotherapy for selected patients with muscle invasive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Treatment of patients with carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

The role of conservative surgery in the treatment of bladder tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Organ preservation for muscle-invasive bladder cancer by transurethral resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Transurethral resection of muscle-invasive bladder cancer: 10-year outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Is TURBT able to cure high risk recurrent superficial or muscle invasive bladder cancer: factors resulting in pT0 radical cystectomy specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Combined intraarterial chemotherapy and radiotherapy in the treatment of Bladder carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Organ preservation for muscle-invasive bladder cancer by preoperative intra-arterial chemotherapy and transurethral resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

The natural history of clinically complete responders to neoadjuvant chemotherapy for urothelial carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Intra-arterial chemotherapy for muscle-invasive bladder cancer following transurethral resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

A systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Partial cystectomy in the treatment of primary and secondary carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Treatment of Muscle Invasive Bladder Cancer: Evidence From the National Cancer Database, 2003 to 2007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Organ-sparing surgery in urology: partial cystectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

In-hospital death and hospital-acquired complications among patients undergoing partial cystectomy for bladder cancer in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Selective bladder preservation with curative intent for muscle‐invasive bladder cancer: A contemporary review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Arterial thromboembolism in cancer patients treated with cisplatin: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Selective bladder‐sparing protocol consisting of induction low‐dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle‐invasive bladder cancer: oncological outcomes of the initial 46 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): a review of the literature and a practical approach to therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Radical cystectomy over the age of 75 is safe and increases survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

A population based assessment of perioperative mortality after cystectomy for bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Comparative survival following different treatment modalities for stage T2 bladder cancer in octogenarians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Radical transurethral resection alone, robotic or partial cystectomy, or extended lymphadenectomy: can we select patients with muscle invasion for less or more surgery?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Use of cystoscopic tattooing in laparoscopic partial cystectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

A novel use of near-infrared fluorescence imaging during robotic surgery without contrast agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Computed tomography imaging-guided percutaneous argon-helium cryoablation of muscle-invasive bladder cancer: initial experience in 32 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

Segmental Resection for Carcinoma of the Bladder: Review of 102 Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2015.11.023

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UROLONC.2015.11.023

1 reference

5 September 2017

1 reference